All In Biotech

Free tool

FAERS Monitor: Regonol

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 017398 or its brand name (Regonol, Pyridostigmine Bromide). Reports on generic versions are filed under their own applications.

Reports

1,915

Serious

1,330

69% of reports

Hospitalization

649

Death reported

177

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • myasthenia gravis192
  • fatigue165
  • dyspnoea147
  • drug ineffective145
  • off label use130
  • asthenia122
  • headache115
  • diarrhoea114
  • nausea96
  • malaise90
  • dizziness76
  • fall72
  • muscular weakness68
  • pain66
  • death65

Reports by year received

View as table
YearReports
20049
200516
200618
200719
200845
200948
201037
201153
201245
201315
201425
201550
201687
201780
2018104
201980
2020128
2021129
2022110
2023177
2024240
2025241
2026158

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,244 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
myasthenia gravisSignal192267.4233.449,510
muscular weaknessSignal686.65.2317
astheniaSignal1223.63.0227
dyspnoeaSignal1472.92.4180
fallSignal722.41.957
fatigueSignal1652.32.0128
malaiseSignal902.31.863
headacheSignal1152.01.760
diarrhoea1141.91.653
dizziness761.71.320
off label use1301.61.432
nausea961.31.18
drug ineffective1451.21.05
pain661.20.92
death650.80.72

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.